🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 12% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
40 Servings
Other Combinations Product Type
12% Evidence Coverage

Supplement Facts — Evidence Check

Calories
9 {Calories}
Total Fat
1 g (2% DV)
337.5 mcg (225% DV)
✅ 2.3× RDA — within safe limits 📚 243 studies (Tier A: 4, B: 133)
RDA 0.15mg This product: 0.3375mg UL 1.1mg
Fat Catabolizor & {Beta}-3 Potentiator
296 mg
Iphoria
400 mg
NorEpiphex Alpha2-Andregenic Blockade Complex
4.5 mg
NorEpiphex M-MAOxidizor-I
20 mg
Thyromimetic Activity Stimulator
250 mcg

Other Ingredients

Bioliquid PolyLipid (polymer-lipid based) delivery system

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (74% of products) Nutrient (53% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

RECOMMENDED USE: As a dietary supplement, the maximum recommended serving is 3 REDLINE(R) BLACK ON BLUE V.2 capsules. However, begin use with one to two REDLINE(R) BLACK ON BLUE V.2 capsules daily to assess tolerance. Never exceed three total capsules daily or in a single dose. As a dietary supplement, take REDLINE(R) BLACK ON BLUE V.2 capsules upon awakening.

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

DO NOT USE IF PREGNANT OR NURSING.

Contains Iodine. Do not use if you are allergic to Iodine.

Manufactured in a facility that processes milk, egg, soy, wheat, tree nuts and peanut.

CAUTION VERY POWERFUL

Consult a physician or licensed qualified health care professional before using this product if you have, or have a family history of, heart disease, thyroid disease, diabetes, high blood pressure, depression or other psychiatric condition, glaucoma, difficulty in urinating, prostate enlargement, or seizure disorder, or if you are using a monoamine oxidase inhibitor (MAOI) or any other dietary supplement, prescription drug, or over-the-counter drug containing ephedrine, pseudoephedrine, or phenylpropanolamine (ingredients found in certain allergy, asthma, cough or cold, and weight control products). Do not exceed recommended serving. Exceeding recommended serving may cause adverse health effects. Discontinue use and call a physician or licensed qualified health care professional immediately if you experience reapid heartbeat, dizziness, severe headache, shortness of breath or other similar symptoms. Individuals who are sensitive to the effects of caffeine or have a medical condition should consult a licensed health care professional before consuming this product. Do not use this product if you are more than 15 pounds over weight. The consumer assumes total liability if this product is used in a manner inconsistent with label guidelines. Do not use for weight reduction.

Discontinue use two weeks prior to surgery.

Do not consume synepherine or caffeine from other sources, including but not limited to, coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine. One Serving of Redline Black on Blue provides 275 mg of caffeine which is less than three cups of coffee.

DO NOT PURCHASE IF SAFETY SEAL IS BROKEN OR MISSING.

Do not use for more than 8 weeks.

WARNING: NOT FOR USED BY INDIVIDUALS UNDER THE AGE OF 18 OR THOSE WITH A MEDICAL CONDITION.

Additional Information

PROTECT FROM HEAT, LIGHT AND MOISTURE.

STORE AT 15-25(0)C (59-77(0)F)

*When combined with increased exercise and a reduced calorie diet.

ALL RIGHTS RESERVED.

BEST BY DATE ON SIDE

NEW

Results not common. Individual results may vary.

V001

Product Details

UPC / SKU 6 10764 38468 3
DSLD Entry Date 2011-11-25
Product Type Other Combinations
Form Capsule
Brand VPX
DSLD ID 2017
Data Updated 2026-04-11

Research Evidence

292 Research Sources
57 Avg Quality Score
160 Meta Analysis
70 Systematic Review
36 Rct
8 Cochrane Review
8 Clinical Trial
3 Regulatory Source
2 Narrative Review
2 Other
1 Guideline
1 Openfda Safety
A Umbilical cord antiseptics for preventing sepsis and death among newborns
Meta Analysis The Cochrane database of systematic reviews 2026
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019
A Interventions for cutaneous molluscum contagiosum
Meta Analysis The Cochrane database of systematic reviews 2017
A Chlorhexidine vs Povidone-Iodine and Incidence of Catheter-Related Infections: A Systematic Review and Meta-Analysis
Meta Analysis JAMA network open 2026
B Radioiodine Remnant Ablation for Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
Meta Analysis JAMA otolaryngology-- head & neck surgery 2021
B Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis
Meta Analysis European journal of nuclear medicine and molecular imaging 2022
B Alcoholic chlorhexidine skin preparation or triclosan-coated sutures to reduce surgical site infection: a systematic review and meta-analysis of high-quality randomised controlled trials
Meta Analysis The Lancet. Infectious diseases 2022
B Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013
B Interventions for ingrowing toenails
Meta Analysis The Cochrane database of systematic reviews 2012
B Interventions for the management of malignant pleural effusions: a network meta-analysis
Systematic Review The Cochrane database of systematic reviews 2016
View all evidence for Iodine →

Compare Similar Products

View all Iodine products →